Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Acta Neuropathol ; 104(5): 471-81, 2002 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-12410395

RESUMEN

Neurofibrillary degeneration, one of the pathological hallmarks of Alzheimer's disease, is not ubiquitous to all brain regions or neurons. While a high degree of vulnerability has been documented for entorhinal cortex, hippocampal and neocortical pyramidal neurons other brain structures are largely spared. Even within highly vulnerable regions such as hippocampus neurons are affected to a variable extent. The molecular basis for this selective susceptibility remains unknown. Neurofibrillary degeneration involves hyperphosphorylation of tau which critically impairs its binding capacity to microtubule and, therefore, is believed to disrupt the axonal cytoskeleton. Recently, Lu et al. [Nature (1999) 399:784] described the ability of the peptidyl-prolyl cis-trans isomerase Pin1 to recover microtubule-binding affinity and microtubule stabilisation of phosphorylated tau. In the present study, we analysed the potential involvement of Pin1 in selective vulnerability of hippocampal neurons to neurofibrillary degeneration in Alzheimer's disease. Pin1 immunoreactivity appeared as cytoplasmic granules affecting hippocampal subfields to a different extent (CA2>subiculum>CA1>CA3/CA4). Since the main markers of granulovacuolar degeneration do not co-label Pin1-immunoreactive granules, we propose that these granules may represent a new lesion in Alzheimer's disease. Neurons containing Pin1 granules were devoid of neurofibrillary tangles. Granular accumulation of Pin1 may correspond to an absence of neurofibrillary lesions in these cells and might be associated with other mechanisms of neuronal degeneration.


Asunto(s)
Enfermedad de Alzheimer/metabolismo , Gránulos Citoplasmáticos/patología , Hipocampo/metabolismo , Isomerasa de Peptidilprolil/biosíntesis , Proteínas tau/biosíntesis , Anciano , Enfermedad de Alzheimer/patología , Precursor de Proteína beta-Amiloide/biosíntesis , Gránulos Citoplasmáticos/metabolismo , Hipocampo/patología , Humanos , Inmunohistoquímica , Peptidilprolil Isomerasa de Interacción con NIMA , Ovillos Neurofibrilares/metabolismo , Neuronas/metabolismo , Neuronas/patología , Fosforilación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA